Cargando…
Radioiodine therapy in differentiated thyroid cancer. There is (still) a great chaos under heaven: is the situation excellent?
Autor principal: | Giovanella, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239370/ https://www.ncbi.nlm.nih.gov/pubmed/36752957 http://dx.doi.org/10.1007/s12020-023-03316-8 |
Ejemplares similares
-
Add-on radioiodine during long-term BRAF/MEK inhibition in patients with RAI-refractory thyroid cancers: a reasonable option?
por: Montes de Jesus, Filipe Miguel, et al.
Publicado: (2023) -
Highway to heaven: mammary gland development and differentiation
por: Melchor, Lorenzo, et al.
Publicado: (2008) -
Molecular Theranostics in Radioiodine-Refractory Differentiated Thyroid Cancer
por: Petranović Ovčariček, Petra, et al.
Publicado: (2023) -
The EANM guideline on radioiodine therapy of benign thyroid disease
por: Campennì, Alfredo, et al.
Publicado: (2023) -
Window to the Future or Door to Chaos?
por: Lopes, Marcelo Antônio Cartaxo Queiroga, et al.
Publicado: (2019)